1esr

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Monocyte chemotactic protein 2 (MCP-2) is a CC chemokine that utilizes, multiple cellular receptors to attract and activate human leukocytes., MCP-2 is a potent inhibitor of HIV-1 by virtue of its high-affinity, binding to the receptor CCR5, one of the major coreceptors for HIV-1., Although a few structures of CC chemokines have been reported, none of, these was determined with the N-terminal pyroglutamic acid residue (pGlu1), and a complete C-terminus. pGlu1 is essential for the chemotactic activity, of MCP-2. Recombinant MCP-2 has Gln1 at the N terminus, 12-15% of which, cyclizes automatically and forms pGlu1. The chemotactic activity of such, MCP-2 mixture, which contains 12-15% pGlu1-form and 85-88% Gln1-form, protein, is approximately 10 times lower when compared with that of fully, cyclized MCP-2 preparation. Therefore, this chemokine is practically, inactive without pGlu1. We have determined the complete crystal structure, of MCP-2 that contains both pGlu1 and an intact C-terminus. With the, existence of pGlu1, the conformation of the N-terminus allows two, additional interactions between the two subunits of MCP-2 dimer: a, hydrogen bond between pGlu1 and Asn17 and a salt bridge between Asp3 and, Arg18. Consequently, both pGlu1 are anchored and buried, and thereby, both, N-terminal regions are protected against protease degradation. We have, also observed not previously reported extended helical nature of the C, terminal region, which covers residues 58-74.
+
Monocyte chemotactic protein 2 (MCP-2) is a CC chemokine that utilizes multiple cellular receptors to attract and activate human leukocytes. MCP-2 is a potent inhibitor of HIV-1 by virtue of its high-affinity binding to the receptor CCR5, one of the major coreceptors for HIV-1. Although a few structures of CC chemokines have been reported, none of these was determined with the N-terminal pyroglutamic acid residue (pGlu1) and a complete C-terminus. pGlu1 is essential for the chemotactic activity of MCP-2. Recombinant MCP-2 has Gln1 at the N terminus, 12-15% of which cyclizes automatically and forms pGlu1. The chemotactic activity of such MCP-2 mixture, which contains 12-15% pGlu1-form and 85-88% Gln1-form protein, is approximately 10 times lower when compared with that of fully cyclized MCP-2 preparation. Therefore, this chemokine is practically inactive without pGlu1. We have determined the complete crystal structure of MCP-2 that contains both pGlu1 and an intact C-terminus. With the existence of pGlu1, the conformation of the N-terminus allows two additional interactions between the two subunits of MCP-2 dimer: a hydrogen bond between pGlu1 and Asn17 and a salt bridge between Asp3 and Arg18. Consequently, both pGlu1 are anchored and buried, and thereby, both N-terminal regions are protected against protease degradation. We have also observed not previously reported extended helical nature of the C terminal region, which covers residues 58-74.
==About this Structure==
==About this Structure==
Line 22: Line 22:
[[Category: x-ray crystallography]]
[[Category: x-ray crystallography]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 15:44:49 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:31:15 2008''

Revision as of 10:31, 21 February 2008


1esr, resolution 2.00Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOTACTIC PROTEIN-2

Overview

Monocyte chemotactic protein 2 (MCP-2) is a CC chemokine that utilizes multiple cellular receptors to attract and activate human leukocytes. MCP-2 is a potent inhibitor of HIV-1 by virtue of its high-affinity binding to the receptor CCR5, one of the major coreceptors for HIV-1. Although a few structures of CC chemokines have been reported, none of these was determined with the N-terminal pyroglutamic acid residue (pGlu1) and a complete C-terminus. pGlu1 is essential for the chemotactic activity of MCP-2. Recombinant MCP-2 has Gln1 at the N terminus, 12-15% of which cyclizes automatically and forms pGlu1. The chemotactic activity of such MCP-2 mixture, which contains 12-15% pGlu1-form and 85-88% Gln1-form protein, is approximately 10 times lower when compared with that of fully cyclized MCP-2 preparation. Therefore, this chemokine is practically inactive without pGlu1. We have determined the complete crystal structure of MCP-2 that contains both pGlu1 and an intact C-terminus. With the existence of pGlu1, the conformation of the N-terminus allows two additional interactions between the two subunits of MCP-2 dimer: a hydrogen bond between pGlu1 and Asn17 and a salt bridge between Asp3 and Arg18. Consequently, both pGlu1 are anchored and buried, and thereby, both N-terminal regions are protected against protease degradation. We have also observed not previously reported extended helical nature of the C terminal region, which covers residues 58-74.

About this Structure

1ESR is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors., Blaszczyk J, Coillie EV, Proost P, Damme JV, Opdenakker G, Bujacz GD, Wang JM, Ji X, Biochemistry. 2000 Nov 21;39(46):14075-81. PMID:11087354

Page seeded by OCA on Thu Feb 21 12:31:15 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools